New China Life Insurance (01336) elected Huang Geng to serve as a member of the Strategy and ESG Committee and the Investment and Asset Liability Management Committee.
New China Life Insurance (01336) announced that on August 26, 2026, at the 11th meeting of the 9th Board of Directors, Mr. Huang Geng was elected as a member of the Strategic and ESG Committee and the Investment and Asset Liability Management Committee of the Board.
New China Life Insurance (01336) announced that on August 26, 2026, at the 11th meeting of the 9th Board of Directors, Mr. Huang Geng was elected as a member of the Board's Strategy and ESG Committee, and the Investment and Asset-Liability Management Committee.
Related Articles
.png)
HANS GP HLDGS (00554) announced its interim results, with the loss attributable to shareholders decreasing by 49.5% to HK$55.32 million.

XINYI ENERGY (03868): New Energy REIT recommended by the National Development and Reform Commission for submission to the China Securities Regulatory Commission.

VIVA BIOTECH (01873) announced its interim results, with an adjusted net profit of 128 million yuan, a year-on-year decrease of 30.08%.
HANS GP HLDGS (00554) announced its interim results, with the loss attributable to shareholders decreasing by 49.5% to HK$55.32 million.
.png)
XINYI ENERGY (03868): New Energy REIT recommended by the National Development and Reform Commission for submission to the China Securities Regulatory Commission.

VIVA BIOTECH (01873) announced its interim results, with an adjusted net profit of 128 million yuan, a year-on-year decrease of 30.08%.

RECOMMEND





